- Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein. Matsunaga, T., Inaba, T., Matsui, H., Okuya, M., Miyajima, A., Inukai, T., Funabiki, T., Endo, M., Look, A.T., Kurosawa, H. Blood (2004)
- Enhanced binding of HLF/DBP heterodimers represents one mechanism of PAR protein transactivation of the factor VIII and factor IX genes. Begbie, M., Mueller, C., Lillicrap, D. DNA Cell Biol. (1999)
- DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF. Hunger, S.P., Brown, R., Cleary, M.L. Mol. Cell. Biol. (1994)
- Expression of E2A-HLF chimeric protein induced T-cell apoptosis, B-cell maturation arrest, and development of acute lymphoblastic leukemia. Honda, H., Inaba, T., Suzuki, T., Oda, H., Ebihara, Y., Tsuiji, K., Nakahata, T., Ishikawa, T., Yazaki, Y., Hirai, H. Blood (1999)
- Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Inaba, T., Inukai, T., Yoshihara, T., Seyschab, H., Ashmun, R.A., Canman, C.E., Laken, S.J., Kastan, M.B., Look, A.T. Nature (1996)
- Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Inaba, T., Roberts, W.M., Shapiro, L.H., Jolly, K.W., Raimondi, S.C., Smith, S.D., Look, A.T. Science (1992)
- Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Hunger, S.P., Ohyashiki, K., Toyama, K., Cleary, M.L. Genes Dev. (1992)
- One hundred sixteen cases of acute liver failure treated with MARS. Novelli, G., Rossi, M., Pretagostini, M., Pugliese, F., Ruberto, F., Novelli, L., Nudo, F., Bussotti, A., Corradini, S., Martelli, S., Berloco, P.B. Transplant. Proc. (2005)
- Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer. Taïeb, J., Artru, P., Baujat, B., Mabro, M., Carola, E., Maindrault, F., Tournigand, C., Krulik, M., Louvet, C., de Gramont, A. Eur. J. Cancer (2002)
- Prognostic factor analysis in advanced gastric cancer patients treated with hydroxyurea, leucovorin, 5-fluorouracil, and cisplatin (HLFP regimen). Louvet, C., Carrat, F., Mal, F., Mabro, M., Beerblock, K., Vaillant, J.C., Cady, J., André, T., Gamelin, E., de Gramont, A. Cancer Invest. (2003)
- The proto-oncogene HLF and the related basic leucine zipper protein TEF display highly similar DNA-binding and transcriptional regulatory properties. Hunger, S.P., Li, S., Fall, M.Z., Naumovski, L., Cleary, M.L. Blood (1996)
- The AD1 and AD2 transactivation domains of E2A are essential for the antiapoptotic activity of the chimeric oncoprotein E2A-HLF. Inukai, T., Inaba, T., Ikushima, S., Look, A.T. Mol. Cell. Biol. (1998)
- DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein. Inaba, T., Shapiro, L.H., Funabiki, T., Sinclair, A.E., Jones, B.G., Ashmun, R.A., Look, A.T. Mol. Cell. Biol. (1994)
- ABCB1 over-expression and drug-efflux in acute lymphoblastic leukemia cell lines with t(17;19) and E2A-HLF expression. Baudis, M., Prima, V., Tung, Y.H., Hunger, S.P. Pediatric blood & cancer. (2006)
- Production of interleukin 6 from human liver cell lines: production of interleukin 6 is not concurrent with the production of alpha-fetoprotein. Matsuguchi, T., Okamura, S., Kawasaki, C., Niho, Y. Cancer Res. (1990)
- Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma. Yamamoto, T., Nagano, H., Sakon, M., Wada, H., Eguchi, H., Kondo, M., Damdinsuren, B., Ota, H., Nakamura, M., Wada, H., Marubashi, S., Miyamoto, A., Dono, K., Umeshita, K., Nakamori, S., Yagita, H., Monden, M. Clin. Cancer Res. (2004)
- Growth arrest by troglitazone is mediated by p27Kip1 accumulation, which results from dual inhibition of proteasome activity and Skp2 expression in human hepatocellular carcinoma cells. Motomura, W., Takahashi, N., Nagamine, M., Sawamukai, M., Tanno, S., Kohgo, Y., Okumura, T. Int. J. Cancer (2004)
- Effective asymmetry in gap junctional intercellular communication between populations of human normal lung fibroblasts and lung carcinoma cells. Zhang, Z.Q., Hu, Y., Wang, B.J., Lin, Z.X., Naus, C.C., Nicholson, B.J. Carcinogenesis (2004)
- E2A basic helix-loop-helix transcription factors in human leukemia. LeBrun, D.P. Front. Biosci. (2003)
- E4BP4 expression is regulated by the t(17;19)-associated oncoprotein E2A-HLF in pro-B cells. Yeung, J., O'Sullivan, E., Hubank, M., Brady, H.J. Br. J. Haematol. (2004)
- E2A/HLF fusion gene in an acute lymphoblastic leukemia patient with disseminated intravascular coagulation and a normal karyotype. Dahéron, L., Brizard, F., Millot, F., Cividin, M., Lacotte, L., Guilhot, F., Brizard, A. Hematol. J. (2002)
- Expression patterns of the hepatic leukemia factor gene in the nervous system of developing and adult mice. Hitzler, J.K., Soares, H.D., Drolet, D.W., Inaba, T., O'Connel, S., MG Rosenfeld, n.u.l.l., Morgan, J.I., Look, A.T. Brain Res. (1999)
- Activation of Galectin-1 gene in human hepatocellular carcinoma involves methylation-sensitive complex formations at the transcriptional upstream and downstream elements. Kondoh, N., Hada, A., Ryo, A., Shuda, M., Arai, M., Matsubara, O., Kimura, F., Wakatsuki, T., Yamamoto, M. Int. J. Oncol. (2003)
- Cardiac output augmentation during hypoxemia improves cerebral metabolism after hypothermic cardiopulmonary bypass. Schultz, J.M., Karamlou, T., Shen, I., Ungerleider, R.M. Ann. Thorac. Surg. (2006)